Eric Vivier
@EricVivier1
Followers
3,000
Following
135
Media
34
Statuses
2,093
Explore trending content on Musk Viewer
Columbus
• 402353 Tweets
Bills
• 140824 Tweets
無料クーポン
• 93411 Tweets
Bret
• 91895 Tweets
Jets
• 90337 Tweets
Yankees
• 73877 Tweets
連休明け
• 72383 Tweets
#WWERaw
• 59039 Tweets
Geraldo
• 44264 Tweets
Rodgers
• 42574 Tweets
Rogan
• 32240 Tweets
Boulos
• 31272 Tweets
Soto
• 29734 Tweets
緊急入院
• 29021 Tweets
当選確率2倍
• 26631 Tweets
Hail Mary
• 25612 Tweets
Buffalo
• 20321 Tweets
Josh Allen
• 19174 Tweets
#BUFvsNYJ
• 15514 Tweets
#RepBX
• 13542 Tweets
Stanton
• 10390 Tweets
Thrilled to see our paper on C5a in COVID-19 out in Nature this morning, prompting to block C5a-C5aR1 in patients with severe disease
12
76
253
Thrilled to share our recent report on the generation of tetraspecific NK cell engagers designed to harness NK cell anti-tumor activity
6
38
244
Thrilled to announce the publication of our latest research in Nature Immunology. Joining forces with 20 laboratories in Europe and USA, we identified the three prominent NK cell subsets in human: NK1, NK2, and NK3:
17
56
242
New immune cell engagers for cancer immunotherapy | Nature Reviews Immunology
0
42
155
Thrilled to announce that our team has been awarded a SYNERGY grant from the ERC to harness Innate Immunity against liver metastasis of colorectal cancer.
14
6
142
Thrilled to share our collective report on a novel classification of human peripheral blood Natural Killer cells. An effort from the MetaNK consortium, a group of 20 laboratories worldwide, intended to serve as a reference point for NK cell research.
1
34
123
Honoré et ravi d'avoir reçu du Pr. Alain Fischer les insignes d'officier dans l'Ordre National du Mérite. Merci aussi ++ à Alain pour sa présentation lumineuse sur la vaccination anti-COVID-19.
13
5
105
All data from our ‘MetaNK’ analysis are available at:
Thanks Muzz Haniffa and Cellatlas for hosting us on the website 🙏
1
27
97
Thrilled to share that our research is featured on the cover of Nature Immunology. Coinciding with Paris 2024 and to celebrate an outstanding opening, we've also depicted the NK1 and NK3 trajectories with the five Olympic Rings, while setting aside a separate sixth ring for NK2
7
9
94
In
@Nature
, Correia et al. demonstrate that
#NKcells
have additional & previously unsuspected anticancer capacities. In our
@NatureNV
article,
@NoellaLopes
& I discuss why
#NKcells
could be at the heart of new potential treatments.
1
26
92
Excellente année 2021 à toutes et à tous! Ravi et honoré de la commencer par une nomination d'officier dans l'Ordre National du Mérite.
Cette année encore, nous ferons de notre mieux pour travailler au service des patients qui en ont besoin.
En route pour de nouvelles aventures!
9
4
90
Proud to join
@EFIS_Immunology
to celebrate
#DayofImmunology
. Pictured here, NK cells may shape a multicellular immune response and long-lasting immune control of tumors. That’s why we’re focused on building the next generation of IO cancer treatments around them
1
12
85
Great honor to have been invited to contribute to the celebration of the 20th anniversary of Nature Reviews Immunology, which truly has been a game changer for review articles. Happy 20 NRI!
0
6
80
Paris & Marseille: des bioclusters au service des patients pour découvrir les traitements de demain et au service de la France pour developper l'industrie de la santé
4
21
80
Happy to share our report on immune checkpoints in COVID-19
2
21
78
On blood and tissue-resident natural killer cells: Immunity
0
23
69
Today is International
#DayofImmunology
and an opportunity to acknowledge the important progress science has made in this field. At
@Innate
Pharma, we are continuing to advance research on NK cells as the next generation of
#immunotherapy
treatments.
2
14
69
Honored and thrilled to share our data on NK cells and ILCs with the Harvard and MIT community
2
4
64
Thrilled that our Cell paper on Monalizumab (André et al.) was chosen by the ‘Cancer Biology and Therapeutics: High-Impact Cancer Research Program’ Class of 2019 at Harvard Medical School as one of the 10 most impactful 2018 scientific papers in the field of oncology
2
15
64
Honored to be named a Highly Cited Researcher 2021 in Immunology, together with 8 other French colleagues by
@ClarivateAG
. See the full list
#HighlyCited2021
7
4
58
NK1, NK2, NK3!
Thrilled to share our collective report on a novel classification of human peripheral blood Natural Killer cells. An effort from the MetaNK consortium, a group of 20 laboratories worldwide, intended to serve as a reference point for NK cell research.
1
34
123
1
7
58
Merci à JJBourdin pour son invitation ce matin sur RMC/LCI pour parler Immunité et COVID-19. A bientôt pour parler du rôle de C5aR et du traitement par Avdoralimab dans les pneumonies sévères
4
15
55
Thrilled to see our last report online!
Online now at Cell: Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
0
16
38
3
7
58
Interested by NK cell engagers?
1
14
54
A Marseille, les premiers résultats encourageants du projet « Explore Covid-19 » via
@gometmedia
3
17
46
Impatient de parler de l'immunothérapie des cancers à l'X. Toutes les disciplines ont un rôle à jouer dans la compréhension et le contrôle des maladies
0
14
53
Merci à Sylvestre Huet d'avoir diffusé ce texte
3
21
49
Thrilled that our scRNAseq study on human bone marrow NK cells in normal and AML conditions is out. Looking forward to comments and feedbacks
2
8
48
Thrilled to see our report on liver ILC1 online ! Great collaboration with our friends in Hefei
0
7
48
Exciting news combos in lung cancer, including monalizumab + durvalumab:
1
4
45
Immune Checkpoint Inhibitors: Anti-NKG2A Antibodies on Board: Trends in Immunology
0
18
45
😉
0
6
42
Happy to share our novel CITE-seq analysis of NK and ILC1 heterogeneity
1
6
41
Covid-19 : comment mieux identifier les patients à risque de forme sévère
Où l'on parle aussi de C5a!
via Le Monde
1
11
39
A novel NK cell engager program (ANKET) between Innate Pharma and Sanofi
1
2
38
Our MICA-antibody drug conjugate report is out in Open Research Europe, the new publication platform from the European Research Council
0
4
38
Proud to be named a
@webofscience
Highly Cited Researcher 2020. See the full list
#HighlyCited2020
1
4
37
Honoré et ravi d’apprendre de Madame Nicole Belloubet, ministre de l’Education Nationale et de la Jeunesse, avoir été nommé directement par décret du Premier ministre, à titre exceptionnel, au grade d’officier dans l’ordre des Palmes académiques. Cet honneur m’oblige.
8
1
36
Marseille and next gen therapies. A success of the fruitful briges between academic research and biotech industry. A pivotal concept of the Marseille Immunopole ecosystem with the patient at the heart of our projects
2
10
35
Marseille accumule les succès dans la recherche biomédicale | Les Echos
0
7
35
Le gendarme du médicament alerte sur les possibles « effets secondaires graves » des traitements testés contre le coronavirus
via Le Monde
4
13
34
1
9
31
Launching of ANKETs: Antibody-based NK cell Engager Therapeutics!
1
0
30
Thrilled to be part of this year's incredible list alongside such talented colleagues! It's an honor to be recognized among these amazing scientists once again. Can't wait to see the disvoveries of the scientific community this year!
IT’S HERE! The Highly Cited Researchers 2023 list has now been published. Discover the most influential
#researchers
the world has to offer:
#HighlyCited2023
0
12
40
5
3
30
Marseille a d'énormes atouts mais il est frustrant de voir ce potentiel gâché ou mal exploité. Soutenons Yvon Berland dans son ambition de conduire la ville au plus haut niveau. Faisons-lui confiance pour mettre en place une équipe légitime basée sur la compétence et l'expertise
1
4
26
"La recherche et l’innovation thérapeutique ne sont pas compatibles avec un repli identitaire" – L'Express
3
10
30
@Prefet13
@univamu
@MaRegionSud
@departement13
@SGPI_avenir
@marseille
Marseille Immunopole (MI), acteur fédérateur de l'immunologie de la métropole Aix-Marseille depuis 2015 devient Marseille Immunologie Biocluster (MIB). La boucle est bouclée! Grande satisfaction et bravo à toutes celles et tous ceux qui ont contribué à cette trajectoire.
1
7
29
Premiers espoirs thérapeutiques dans la lutte contre les « tempêtes immunitaires », les formes les plus graves du Covid-19
via Le Monde
2
7
28
@InnatePharma
@AstraZeneca
@myESMO
Great news! It all began by basic immunology research: Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases ()
4
2
27
« Les essais cliniques se sont mis en place avec une rapidité inédite » : enquête sur les futurs traitements du Covid-19
via Le Monde
1
8
27
Great collaboration with the Bing Su lab at the Shanghai Institute of Immunology
0
6
25
Info on the C5a-C5aR pathway in COVID-19
1
9
26
If you are interested by the kinetics of ILC development in humans:
0
8
27
Truly an outstanding exemple of the bridges between basic research and medecine on which one builts a better future. Warm congrats and deep respect to all involved.
0
4
26
Thrilled to talk at Institute of Immunity and Transplantation, University College London on the Harnessing of NK cells in cancer therapies via the Antibody-based NK cell engager therapeutics (ANKET) from Innate Pharma
1
2
25
Excellents échanges à l'X avec l'équipe de l'Institut Polytechnique de Paris à propos du Paris Saclay Cancer Cluster. Tous ensemble pour combattre le cancer.
0
2
23
2
9
22
1
3
21
0
10
21
Ravi de présenter l’immunothérapie sur FRANCE INTER / GRAND BIEN VOUS FASSE / ALI REBEIHI
28 JANVIER À 10H
0
5
21
Très heureux de voir le livre maintenant annoncé!Immunothérapie des cancers - Éditions Odile Jacob
1
14
20
Honored and thrilled to participate to the IUIS-Frontier webinar series on COVID-19
1
8
19
Nice set of data confirming our findings published last year (Carvelli, Demaria, Vély et al. Nature 2020):
0
3
19
Great meeting with Shanghai Institute of Immunology. Looking forward to industrial and academic partnerships in immunology of cancers and beyond. Let’s build bridges between academic research and biopharmaceutical industry, between Shanghai and Marseille, between China and France
0
6
19
Immunothérapie 2.0 | Eric VIVIER | TEDxAix - YouTube
3
10
18
Delighted to present the Paris Saclay Cancer Cluster on Thursday, July 7 at X, with presentations by Harvey Lodish (MIT), Vanessa Malier (Kurma) and Nicolas Manel (Curie). Together, let's invent tomorrow's oncology for patients
0
3
17
Cancer : la révolution de l'immunothérapie | CNRS Le journal
1
14
18
Looking forward to present the results of our research to provide innovative treatment against cancer
@EricVivier1
, Innate Senior Vice President and Chief Scientific Officer, to participate in the
@International
Union of Immunological Societies (
@iuis_online
), to be held from November 27 to December 1, 2023, in Cape Town, South Africa.
#IUIS2023
#InnatePharma
#Immunotherapy
0
2
13
0
2
15
VIDÉO - La France a tout pour réussir : Paris Saclay Cancer Cluster, le nouvel écosystème français de lutte anti-cancer - 12/02 via
@bfmbusiness
0
3
16
Keystone Symposia Conference | Innate and Non-Classical Immune Cells in Cancer Immunotherapy - Program
0
3
17
Important
Targeting the PD1 and PDL1 axis has paved the way for a new era of clinical care in
#cancer
.
#immunotherapy
trials remain the dominant force in oncology. IO trials have doubled in 2020 with a strong surge of combinations & growing challenges in recruitment
0
23
92
0
3
16
Many thanks for the very nice preview !
Marina Cella & Vincent Peng preview the
#ImmunityResource
from
@EricVivier1
&
@AdelineCrinier
&co profiling human & mouse NK cells "Seq-ing out the Killers of Mice and Men" Orig:
0
2
12
1
4
16